ALAN J MAIN
CIK 1227372 · EVP, Innov & Chem Sciences · last filed 2025-03-03
ALAN J MAIN is an EVP, Innov & Chem Sciences who has filed 37 SEC Form 4 insider transactions across 2 companies since 2007. The most recent filing, for LXRX, was dated Mar 3, 2025. Current disclosed insider exposure totals $540.3K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$540.3K
2
37
$0
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| LXRX | EVP, Innov & Chem Sciences | 281,391 | $1.92 | $540.3K | $0 | 36 | 2025-03-03 |
| LEXICON PHARMACEUTICALS, INC. (LEXG) Delisted | EVP, Pharmaceutical Research | — | — | — | $0 | 1 | 2007-02-15 |
Recent Filings
37 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2025-03-03 | LXRX | Mixed | +83,380 | -$29.1K | EDGAR |
| 2025-02-18 | LXRX | Grant (A) | — | $0 | EDGAR |
| 2024-02-29 | LXRX | Mixed | +43,138 | -$63.9K | EDGAR |
| 2024-02-12 | LXRX | Grant (A) | — | $0 | EDGAR |
| 2023-03-01 | LXRX | Mixed | +36,997 | -$45.5K | EDGAR |
| 2023-02-13 | LXRX | Grant (A) | — | $0 | EDGAR |
| 2022-02-28 | LXRX | Mixed | +34,894 | -$56.3K | EDGAR |
| 2022-02-14 | LXRX | Grant (A) | — | $0 | EDGAR |
| 2021-03-02 | LXRX | Mixed | +36,055 | -$146.8K | EDGAR |
| 2021-02-16 | LXRX | Grant (A) | — | $0 | EDGAR |